OMCL | OmnicellNASDAQTechnologyCommon stock golden cross and death cross projections, cross tests and history

$35.46
-$0.95 (-2.61%)

Omnicell (OMCL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits below the 50 and the 200; on the daily it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $35.46 vs 50 $34.64 / 200 $38.89
Projection
No cross projected
Test
No active test
Last cross
Death cross 17 Aug 2026 ยท projected 15 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $36.65 vs 50 $39.59 / 200 $41.06
Projection
Golden cross estimated 15+ weeks out
Test
No active test
Last cross
Death cross week of 26 Dec 2022 ยท projected 28 bars out

Cross history

26
crosses on record since 2018
12 golden14 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
17 Aug 2026Death moderatedaily15 bars outNot tested
17 Aug 2026Death4-hour25 bars outNot tested
20 May 2026Golden4-hour27 bars outNot tested
9 Mar 2026Death4-hour30 bars out3 bar cross test
19 Nov 2025Golden moderatedaily18 bars outNot tested

About OMCL

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$18.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorTechnology
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.